The BMS-986141 Diaries
If you wish to contribute, please do not immediately edit these pages, and rather take a look at the Timeline Dialogue.A.G.H. has been given analysis funding from Bayer AG and is particularly a founder and shareholder of AMZL TherapeuticsThe drug inhibits The expansion of tumor cells by limiting their capacity to mend destroyed DNA. ATR inhibitors